{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:13:41Z","timestamp":1788952421436,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["No.BMI\/11\/(65)\/2022"],"award-info":[{"award-number":["No.BMI\/11\/(65)\/2022"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/FST\/LSI \\u2013 667\/2016"],"award-info":[{"award-number":["SR\/FST\/LSI \\u2013 667\/2016"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR \/PURSE Phase 2\/38 (G)"],"award-info":[{"award-number":["SR \/PURSE Phase 2\/38 (G)"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008762","name":"Tamil Nadu State Council for Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbrc.2026.154414","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:01:23Z","timestamp":1786201283000},"page":"154414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multi-complex pharmacophore mapping for the repurposing of FDA drugs as HTLV-1 protease inhibitors: Toward novel anti-HTLV-1 therapeutics"],"prefix":"10.1016","volume":"834","author":[{"given":"Gurunathan","family":"Rubhashri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154414_bib1","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154414_bib2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1126\/science.6981847","article-title":"A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia","volume":"218","author":"Kalyanaraman","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2026.154414_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1021\/acschembio.0c00975","article-title":"Inhibiting HTLV-1 protease: a viable antiviral target","volume":"16","author":"Lockbaum","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.bbrc.2026.154414_bib4","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1080\/07391102.2022.2078411","article-title":"Repurposing antiviral drugs against HTLV-1 protease by molecular docking and molecular dynamics simulation","volume":"41","author":"Jahantigh","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2026.154414_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1128\/CMR.00063-09","article-title":"Epidemiology, treatment, and prevention of human T-cell leukemia virus type 1-associated diseases","volume":"23","author":"Gon\u00e7alves","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bbrc.2026.154414_bib6","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1021\/acs.jmedchem.5b00346","article-title":"Privileged structures meet Human T-Cell Leukemia Virus-1 (HTLV-1): C2-symmetric 3,4-Disubstituted pyrrolidines as nonpeptidic HTLV-1 protease inhibitors","volume":"58","author":"Kuhnert","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154414_bib7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/aid.2011.0342","article-title":"Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research","volume":"28","author":"Beilke","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.bbrc.2026.154414_bib8","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1038\/s41388-018-0163-x","article-title":"Stability of HTLV-2 antisense protein is controlled by PML nuclear bodies in a SUMO-dependent manner","volume":"37","author":"Dubuisson","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2026.154414_bib9","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1080\/15384101.2020.1779455","article-title":"The effect of alcoholic extract from Eucalyptus camaldulensis leaves on HTLV-1 tax activities","volume":"19","author":"Abu-Jafar","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bbrc.2026.154414_bib10","series-title":"Cancer and AIDS : Part II: Cancer Pathogenesis and Epidemiology","first-page":"21","article-title":"Global HTLV-1\/2 burden and associated diseases","author":"Williams","year":"2019"},{"key":"10.1016\/j.bbrc.2026.154414_bib11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.antiviral.2016.10.015","article-title":"Reducing the global burden of HTLV-1 infection: an agenda for research and action","volume":"137","author":"Willems","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrc.2026.154414_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1186\/s12889-016-3366-5","article-title":"Human T-Lymphotropic virus type 1 infection in an Indigenous Australian population: epidemiological insights from a hospital-based cohort study","volume":"16","author":"Einsiedel","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bbrc.2026.154414_bib13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fmicb.2018.00278","article-title":"How to Control HTLV-1-Associated Diseases: preventing de Novo Cellular Infection Using Antiviral Therapy","volume":"9","author":"Pasquier","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.154414_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3851\/IMP2090","article-title":"Kinetic characterization of newly discovered inhibitors of various constructs of human T-cell leukemia virus-1 (HTLV-1) protease and their effect on HTLV-1-infected cells","volume":"17","author":"Demir","year":"2012","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.bbrc.2026.154414_bib15","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1039\/C4MB00486H","article-title":"Molecular insights of protein contour recognition with ligand pharmacophoric sites through combinatorial library design and MD simulation in validating HTLV-1 PR inhibitors","volume":"11","author":"Selvaraj","year":"2015","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.bbrc.2026.154414_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/life11020127","article-title":"Biochemical characterization, specificity and inhibition studies of HTLV-1, HTLV-2, and HTLV-3 proteases","volume":"11","author":"Kassay","year":"2021","journal-title":"Life"},{"issue":"Suppl 2","key":"10.1016\/j.bbrc.2026.154414_bib17","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1086\/313853","article-title":"HIV-1 protease inhibitors","volume":"30","author":"Eron","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bbrc.2026.154414_bib18","doi-asserted-by":"crossref","DOI":"10.5812\/jjhr.92813","article-title":"Curcumin as an herbal inhibitor candidate against HTLV-1 protease","author":"Karbalaei","year":"2019","journal-title":"Jentashapir J. Health Res"},{"key":"10.1016\/j.bbrc.2026.154414_bib19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nsb1203-980","article-title":"Announcing the worldwide protein data bank","volume":"10","author":"Berman","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbrc.2026.154414_bib20","doi-asserted-by":"crossref","first-page":"18332","DOI":"10.1073\/pnas.0509335102","article-title":"Crystal structure of human T cell leukemia virus protease, a novel target for anticancer drug design","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154414_bib21","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jmb.2010.06.052","article-title":"Crystal structures of inhibitor complexes of human T-cell leukemia virus (HTLV-1) protease","volume":"401","author":"Satoh","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154414_bib22","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1021\/jm500402c","article-title":"Structural basis for HTLV-1 protease inhibition by the HIV-1 protease inhibitor indinavir","volume":"57","author":"Kuhnert","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbrc.2026.154414_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2026.154414_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2020.113968","article-title":"Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation","volume":"318","author":"El-Hoshoudy","year":"2020","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bbrc.2026.154414_bib25","article-title":"Discovery of novel hepatitis C virus NS5B polymerase inhibitors by combining random forest, multiple e-Pharmacophore modeling and docking","volume":"11","author":"Wei","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154414_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jmgm.2017.04.025","article-title":"Multicomplex-based pharmacophore modeling coupled with molecular dynamics simulations: an efficient strategy for the identification of novel inhibitors of PfDHODH","volume":"75","author":"Manhas","year":"2017","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.bbrc.2026.154414_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/minf.201200169","article-title":"Multiple e-Pharmacophore modeling combined with high-throughput virtual screening and docking to identify potential inhibitors of \u03b2-Secretase(BACE1)","volume":"32","author":"Palakurti","year":"2013","journal-title":"Mol. Inf."},{"key":"10.1016\/j.bbrc.2026.154414_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1432-1033.1977.tb11885.x","article-title":"The protein data bank. A computer-based archival file for macromolecular structures","volume":"80","author":"Bernstein","year":"1977","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbrc.2026.154414_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/minf.201400120","article-title":"Design of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors: virtual screening, synthesis and in vitro biological activities","volume":"34","author":"Devi","year":"2015","journal-title":"Mol. Inf."},{"key":"10.1016\/j.bbrc.2026.154414_bib30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.patrec.2005.10.010","article-title":"An introduction to ROC analysis","volume":"27","author":"Fawcett","year":"2006","journal-title":"Pattern Recognit. Lett."},{"key":"10.1016\/j.bbrc.2026.154414_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/ci600426e","article-title":"Evaluating virtual screening methods: good and bad metrics for the \u201cearly recognition\u201d problem","volume":"47","author":"Truchon","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2026.154414_bib32","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1021\/ci900212v","article-title":"Novel method for generating structure-based pharmacophores using energetic analysis","volume":"49","author":"Salam","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2026.154414_bib33","doi-asserted-by":"crossref","first-page":"23684","DOI":"10.1021\/acsomega.5c02627","article-title":"In silico evaluation of bioactive compounds from Cucumis anguria L. as potential inhibitors of antibiotic-resistant New Delhi Metallo-\u03b2-Lactamase (NDM-1)","volume":"10","author":"Kulandhaivel","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2026.154414_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2026.109103","article-title":"Bioactivity-guided isolation of alkaloids and chlorophyll-derived compounds from Murraya koenigii with anti-inflammatory, anti-allergic, and SARS-CoV-2 entry-inhibitory activities","volume":"81","author":"Faruk","year":"2026","journal-title":"Food Biosci."},{"key":"10.1016\/j.bbrc.2026.154414_bib35","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/07391102.2023.2283780","article-title":"Identification of synthetically tractable MERS-CoV main protease inhibitors using structure-based virtual screening and molecular dynamics potential of mean force (PMF) calculations","volume":"43","author":"Tripathi","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2026.154414_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2026.154414_bib37","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12247-024-09894-y","article-title":"Computational identification of bioactive molecules from Caralluma stalagmifera L. as potential VEGFR2 inhibitors for endometriosis treatment","volume":"20","author":"Jesudass","year":"2025","journal-title":"J Pharm Innov"},{"key":"10.1016\/j.bbrc.2026.154414_bib38","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1007\/s11030-025-11343-y","article-title":"Decoding pH-dependent structural dynamics of CHIKV nsP2 protease: insights from computational antiviral targeting","volume":"30","author":"Gurunathan","year":"2026","journal-title":"Mol Divers"},{"key":"10.1016\/j.bbrc.2026.154414_bib39","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1021\/acs.jcim.3c01344","article-title":"DSSP in GROMACS: tool for defining secondary structures of proteins in trajectories","volume":"64","author":"Gorelov","year":"2024","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bbrc.2026.154414_bib40","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1080\/07391102.2019.1657499","article-title":"Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Mycobacterium Tuberculosis","volume":"38","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2026.154414_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgeb.2025.100531","article-title":"Computational identification of dual COX-1 and NIK inhibitors from marine microalga Chlorella vulgaris","volume":"23","author":"Samantaray","year":"2025","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.bbrc.2026.154414_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40040","article-title":"Deciphering the conformational changes induced by high-risk nsSNPs in \u03b2-lactoglobulin","volume":"10","author":"Sahoo","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bbrc.2026.154414_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108149","article-title":"Comprehending the pharmacological mechanism of marine phenolic acids in bladder cancer therapy against matrix metalloproteinase 9 protein by integrated network pharmacology and in-silico approaches","volume":"112","author":"Roney","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.bbrc.2026.154414_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304490","article-title":"A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: molecular docking, ADME profiling and molecular dynamics simulations","volume":"19","author":"Azmal","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154414_bib45","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1080\/07391102.2024.2323701","article-title":"Repurposing of SARS-CoV-2 compounds against marburg virus using MD simulation, mm\/GBSA, PCA analysis, and free energy landscape","volume":"43","author":"Kumar","year":"2025","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbrc.2026.154414_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharma.2026.01.003","article-title":"Phytochemical evaluation of Glossocardia bosvallia (Linn. f.) Dc.: a dual approach against resistant Staphylococcus aureus","author":"Kulandhaivel","year":"2026","journal-title":"Ann. Pharm. Fr."},{"key":"10.1016\/j.bbrc.2026.154414_bib47","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2174\/157489312803901009","article-title":"Steered Molecular Dynamics-A promising tool for drug design","volume":"7","author":"Li","year":"2012","journal-title":"Curr. Bioinf."},{"key":"10.1016\/j.bbrc.2026.154414_bib48","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1021\/ct100494z","article-title":"g_wham\u2014A free weighted histogram analysis implementation including robust error and autocorrelation estimates","volume":"6","author":"Hub","year":"2010","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.bbrc.2026.154414_bib49","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1002\/jcc.540130812","article-title":"THE weighted histogram analysis method for free-energy calculations on biomolecules. I. The method","volume":"13","author":"Kumar","year":"1992","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbrc.2026.154414_bib50","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.sjbs.2020.10.023","article-title":"In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches","volume":"28","author":"Sahayarayan","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.bbrc.2026.154414_bib51","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41598-021-83626-x","article-title":"Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein","volume":"11","author":"Opo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2026.154414_bib52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00044-019-02486-3","article-title":"Discovery of a nanomolar glyoxalase-I inhibitor using integrated ligand-based pharmacophore modeling and molecular docking","volume":"29","author":"Al-Shar\u2019i","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bbrc.2026.154414_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10822-025-00751-9","article-title":"Integrating traditional and modern approaches for comprehensive pharmacophore map validation in drug discovery","volume":"40","author":"Amin","year":"2026","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bbrc.2026.154414_bib54","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s44371-026-00603-x","article-title":"Pharmacophore based discovery of dual inhibitors targeting TOP1 and TOP2A in resistant triple negative breast cancer","volume":"3","author":"Onaji","year":"2026","journal-title":"Discov. Chem."},{"key":"10.1016\/j.bbrc.2026.154414_bib55","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/bip.22780","article-title":"New directions for protease inhibitors directed drug discovery","volume":"106","author":"Hamada","year":"2016","journal-title":"Biopolymers"},{"key":"10.1016\/j.bbrc.2026.154414_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013208","article-title":"Multiple routes and milestones in the folding of HIV\u20131 Protease monomer","volume":"5","author":"Bonomi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2026.154414_bib57","first-page":"19","article-title":"Design of new potent HTLV-1 protease inhibitors: in silico study","volume":"5","author":"Kheirabadi","year":"2016","journal-title":"Mol. Biol. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154414_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S1074-5521(03)00104-2","article-title":"Understanding HTLV-I protease","volume":"10","author":"Shuker","year":"2003","journal-title":"Chem. Biol."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26011782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:33:34Z","timestamp":1788950014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26011782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":58,"alternative-id":["S0006291X26011782"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154414","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-complex pharmacophore mapping for the repurposing of FDA drugs as HTLV-1 protease inhibitors: Toward novel anti-HTLV-1 therapeutics","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154414","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154414"}}